Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
10.65
-0.44 (-3.97%)
Jun 5, 2026, 12:45 PM EDT - Market open
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $627.05 million as of June 5, 2026. Its market cap has increased by 163.30% in one year.
Market Cap
627.05M
Enterprise Value
517.42M
1-Year Change
163.30%
Ranking
Category
Stock Price
$10.65
Market Cap Chart
Since March 16, 1993, Tenax Therapeutics's market cap has increased from $110.17M to $627.05M, an increase of 469.15%. That is a compound annual growth rate of 5.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 652.96M | 32.03% |
| Dec 31, 2025 | 494.55M | 126.39% |
| Dec 31, 2024 | 218.45M | 3,233.86% |
| Dec 29, 2023 | 6.55M | 31.60% |
| Dec 30, 2022 | 4.98M | -81.01% |
| Dec 31, 2021 | 26.21M | 11.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 692.30M |
| Candel Therapeutics | 679.22M |
| Design Therapeutics | 672.04M |
| CorMedix | 669.98M |
| Relmada Therapeutics | 661.86M |
| Zevra Therapeutics | 660.32M |
| BridgeBio Oncology Therapeutics | 659.28M |
| Aclaris Therapeutics | 657.82M |